201 related articles for article (PubMed ID: 37140987)
1. Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.
Sattari M; Kohvakka A; Moradi E; Rauhala H; Urhonen H; Isaacs WB; Nykter M; Murtola TJ; Tammela TLJ; Latonen L; Bova GS; Kesseli J; Visakorpi T
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37140987
[TBL] [Abstract][Full Text] [Related]
2. Revealing metastatic castration-resistant prostate cancer master regulator through lncRNAs-centered regulatory network.
Ferraz RS; Cavalcante JVF; Magalhães L; Ribeiro-Dos-Santos Â; Dalmolin RJS
Cancer Med; 2023 Sep; 12(18):19279-19290. PubMed ID: 37644825
[TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
[TBL] [Abstract][Full Text] [Related]
4. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
5. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.
Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D
Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147
[TBL] [Abstract][Full Text] [Related]
7. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
Das R; Feng FY; Selth LA
Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
[TBL] [Abstract][Full Text] [Related]
9. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y
Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357
[TBL] [Abstract][Full Text] [Related]
10. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
[TBL] [Abstract][Full Text] [Related]
12. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer.
Crea F; Watahiki A; Quagliata L; Xue H; Pikor L; Parolia A; Wang Y; Lin D; Lam WL; Farrar WL; Isogai T; Morant R; Castori-Eppenberger S; Chi KN; Wang Y; Helgason CD
Oncotarget; 2014 Feb; 5(3):764-74. PubMed ID: 24519926
[TBL] [Abstract][Full Text] [Related]
13. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
14. [Long non-coding RNAs in prostate cancer: An update].
Wu PG; Zhang YX
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
[TBL] [Abstract][Full Text] [Related]
15. Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.
Chen G; Qin X; Wang Y; Gao B; Ling M; Yin W; Li Y; Pan B
Cell Cycle; 2022 Aug; 21(16):1684-1696. PubMed ID: 35414328
[TBL] [Abstract][Full Text] [Related]
16. Identification of androgen response-related lncRNAs in prostate cancer.
Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S
Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203
[TBL] [Abstract][Full Text] [Related]
17. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
Li ZF; Xiao N; Yao YW; Yao ZF
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
[TBL] [Abstract][Full Text] [Related]
18. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.
Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S
Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300
[TBL] [Abstract][Full Text] [Related]
19. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]